|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61P 1/00 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3275442 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16768810.0 |
| Date of filing the European patent application | 2016-03-23 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2016/059162 |
| Date | 2016-03-23 |
| (87) | Number | WO 2016/152907 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 201562138058 P | 2015-03-25 | US |
| (72) |
SHIBATA Tatsuhiro , JP
ARAI Yasuhito , JP
NOMOTO Kenichi , US
NAKAMURA Tomio , JP
TSURUOKA Akihiko , JP
MIYANO Saori , JP
|
| (73) |
National Cancer Center ,
5-1-1, Tsukiji
Chuo-ku, Tokyo 1040045,
JP
Eisai R&D Management Co., Ltd. , 4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP |
| (54) | THERAPEUTIC AGENT FOR BILE DUCT CANCER |
| THERAPEUTIC AGENT FOR BILE DUCT CANCER |